Collectively, these data show how hypoxic cancer-derived EVs, via transfer of MIR-301, MIR-451, and CCL2, may be able to interfere with dendritic cells’ functioning, resulting in reduced antitumor immune reactions (Figure 2D). This evidence concerns the gene CCL2 and cancer.